−0.0324EUR
−3.71 MEUR
121.26 KEUR
About PROSTATYPE GENOMICS AB
Sector
CEO
Fredrik Persson
Headquarters
Solna
Website
Employees (FY)
7
Founded
2007
ISIN
SE0014684569
FIGI
BBG00ZVW5ZK2
Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. It helps clinicians and patients to make correct treatment decisions. The company was founded in 2007 and is headquartered in Solna, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange PROSTATYPE GENOMICS AB stocks are traded under the ticker PGO.
Yes, you can track PROSTATYPE GENOMICS AB financials in yearly and quarterly reports right on TradingView.
PGO net income for the last quarter is −2.11 M EUR, while the quarter before that showed −1.51 M EUR of net income which accounts for −39.01% change. Track more PROSTATYPE GENOMICS AB financial stats to get the full picture.
No, PGO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PGO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROSTATYPE GENOMICS AB stock right from TradingView charts — choose your broker and connect to your account.
As of May 9, 2024, the company has 7.00 employees. See our rating of the largest employees — is PROSTATYPE GENOMICS AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROSTATYPE GENOMICS AB EBITDA is −3.35 M EUR, and current EBITDA margin is −2.76 K%. See more stats in PROSTATYPE GENOMICS AB financial statements.